Aurelien MARABELLE

Aurelien Marabelle: MD, PhD, is a Senior Medical Oncologist in the Drug Development Department (DITEP), a group leader in Prof Laurence Zitvogel’s lab (INSERM U1015) and the Clinical Director of the Cancer Immunotherapy Program at Gustave Roussy.

He joined the faculty in Oct 2014. He got a MSc & PhD in Oncology & Immunology from Ecole Normale Supérieure de Lyon, King’s College London & University of Lyon. He did a post-doctoral fellowship in Prof Ronald Levy’s lab at Stanford University, California.

He trained at the University of Paris VI medical school and received his medical degree from the University of Clermont-Ferrand. He completed his residency training in between Clermont-Ferrand & Lyon, followed by a clinical fellowship at Léon Bérard Cancer Center in Lyon.

Dr Marabelle is a member of ASCO & AACR. Dr Marabelle is board-certified in Pediatric Oncology & Cell Therapy.

PEGASCY governance

Founders

MD, phD
 

Jean-harles Soria: is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy

Jean-Charles

SORIA

Chief Executive Officer
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

MD, phD
 

Fabrice André: Director of Research at Gustave Roussy since February 2020, Prof. Fabrice André coordinates the Institute's medical-scientific research programs, in conjunction with the Medical Director.

Fabrice

ANDRÉ

 

MD, phD
 

Aurelie Marabelle: MD, PhD, is a Senior Medical Oncologist in the Drug Development Department (DITEP), a group leader in Prof Laurence Zitvogel’s lab (INSERM U1015)

Aurélien

MARABELLE

MBA
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sébastien

BAZIN

MBA
 

Thierry Bruhat: he spent more than 20 years in supporting innovation projects and policies based on cooperation between companies, research

Thierry

BRUHAT

Board

Chairman
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

Censor
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sebastien

BAZIN

Directors
 

Fabrice Barlesi: As a specialist in lung cancer, precision medicine and cancer immunology

Fabrice

BARLESI

Directors
 

Olivier Edwards: is a lawyer who advises emerging companies and venture capital funds on investment, merger & acquisition matters with an emphasis on cross-border deals.

Olivier

EDWARDS

COO/CFO
 

Jean-Paul Alves, BSc in Economy, Graduated from EM Lyon and Post Graduated in Managerial Accounting, Chartered Accounting and Tax, joined Pegascy in 2020 as Chief Financial Officer.

Jean-Paul

ALVES